The Chromatin Regulatory System
This system performs a crucial function in our bodies. By unpacking the 3D structure of DNA, it orchestrates gene expression, telling our cells when to turn certain genes on, and when to turn them off.
Unraveling Disease
Our precision therapeutic candidates remodel the shape of DNA to tackle disease.
A Leading Culprit of Disease
0%
More than half of all cancers—and many other diseases—are associated with breakdowns in the chromatin regulatory system.
A New Class of Therapeutics
Foghorn is pioneering a new class of medicines that treat serious disease by correcting abnormal gene expression. These precision therapeutic candidates target disease dependencies within the chromatin regulatory system, which means they change how genes turn on and off. Our therapies have the potential to be the next wave of medicines for cancer and other diseases.
Our Vision
At Foghorn Therapeutics, we are leveraging our unique insights into this fundamental system to pioneer a new class of medicines that treat serious diseases by correcting abnormal gene expression in oncology and beyond.
Our Leadership
Our management team has extensive experience discovering, developing and commercializing new therapies.
Join the Team
We are looking for team members who share our passion for collaborative innovation in discovering new therapeutics that have the potential to transform the lives of people with a wide spectrum of disease.
Investors
Find out more about our company, accomplishments, news, and latest events.